Rezul'taty issledovaniya effektivnosti, perenosimosti i bezopasnosti preparata Artradol u patsientov s vertebrogennoy tservikobrakhialgiey


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This study was aimed to the evaluation of clinical efficacy, tolerability and safety of artradol in patients with cervical spine dorsopathies. The comparative clinical evaluation of 90 patients aged from 35 to 70 years was performed. Patients were divided into two groups. Main group of patients received artradol in addition to standard therapy of dorsopathies; comparison group received standard therapy alone. The results of study allow to conclude that artradol has a positive effect on the dynamics of neurological manifestations, good tolerability and high efficacy.

Full Text

Restricted Access

About the authors

M. V Putilina

Email: profput@mail.ru

A. V Fedotova

References

  1. Алексеева Л.И. Хондроитин сульфат: механизмы действия, эффективность и безопасность при терапии остеоартроза // Современная ревматология 2012. № 3.
  2. Зоткин Е.Г., Шкиреева С.Ю. Особенности ведения пациентов с остеоартрозом в первичном звене здравоохранения // РМЖ 2012. № 27.
  3. Клинические рекомендации. Ревматология. М., 2010. С. 326.
  4. Никищенкова А.С., Жулев С.Н., Жулев Н.М., Овсянникова Н.А. Артрадол (хондроитина сульфат) в лечении остеохондроза и спондилоартроза позвоночника // Consilium Medicum. Неврология/ревматология (Прил.) 2012. № 2.
  5. Фоломеева О.М., Амирджанова В.Н., Якушева Е.О. Анализ структуры XIII класса болезней // Рос. ревматол. 1998. № 1. С. 2-7.
  6. Bana G, Jamard B, Verrouil E, et al. Chondroitin sulfate in the management of hip and knee OA: an overview. Adv Pharmacol 2006;53:507-22.
  7. Bruyere O, Burlet N, Delmas PD, et al. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system. BMC Musculoskelet Dis 2008;9:165.
  8. Campo GM, Avenoso A, Campo S, et al. Chondroitin sulfate: antioxidant properties and beneficial effects. Mini Rev Med Chem 2006;6(12):1311-20.
  9. Campo GM, Avenoso A, Campo S, et al. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem 2009;106(1):83-92.
  10. Caraglia M, Beninati SD, Alessandro AM, et al. Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice. Exp Mol Med 2005;37:476-81.
  11. Chan PS, Caron JP, Rosa GJ, et al. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthr Cartil 2005;13(5):387-94.
  12. Cho SY, Sim JS, Jeong CS, et al. Effects of low molecular weight chondroitin sulfate on type II collagen-induced arthritis in DBA/1J mice. Biol Pharm Bull 2004;27(1):47-51.
  13. Chou MM, Vergnolle N, McDougall JJ, et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med (Maywood) 2005;230(4): 255-62.
  14. Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate and the two in combination for painful knee osteoarthritis. N Engl J Med 2006;354(8):795-808.
  15. Conte A, Volpi N, Palmieri L. et al. Biochemical and pharmacological aspects of oral treatment with chondroitin sulfate. Arzneim Drug Res 1995;45:918-25.
  16. DeHaan M, Guzman J, Bayley M. et al. Knee osteoarthritis clinical practice guidelines -how are we doing? J Rheumatol 2007; 34:2099-105.
  17. Gabay C, Medinger-Sadowski C, Gascon D, et al. Symptomatic effects of chondroitin 4 and chondroitin 6 sulfate on hand osteoarthritis: a randomized, doubleblind, placebo-controlled clinical trial at a single center. Arthr Rheum 2011;63(11):3383-91.
  18. Hochberg MC. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebocontrolled trials of 2-year duration. Osteoarthr Cartil 2010;18(Suppl 1):28-31.
  19. Imada K, Oka H, Kawasaki D, et al. Anti-arthritic action mechanism of natural chondroitin sulfate in human articular chondrocytes and synovial fibroblasts. Biol Pharm Bull 2010; 33(3):210-14.
  20. Kahan A, Uebelhart D, de Vathaire F, et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a twoyear, randomized, double-blind, placebocontrolled trial. Arthr Rheum 2009;60(2):524-33.
  21. Kwan Tat S, Schweitzer H, Montag K, et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheum 2000;27(1):205-11.
  22. Jomphe C, Gabriac M, Hale TM, et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappa B in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol 2008;102:59-65.
  23. Largo R, Roman-Blas JA, Moreno-Rubio J. Chondroitin sulfate improves synovitis in rabbits with chronic antigeninduced arthritis. Osteoarthr Cartil 2010;18:17-23.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies